Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2023-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Fagron
|
— |
| Domicile of entity | — |
België
|
— |
| Legal form of entity | — |
NV
|
— |
| Country of incorporation | — |
België
|
— |
| Address of entity's registered office | — |
Venecoweg 20A te Nazareth
|
— |
| Principal place of business | — |
Rotterdam
|
— |
| Description of nature of entity's operations and principal activities | — |
is een toonaangevende mondiale onderneming actief in farmaceutische bereidingen en richt zich op het leveren van gepersonaliseerde farmaceutische zorg aan ziekenhuizen, apotheken, klinieken en patiënten in 30+ landen wereldwijd.
|
— |
| Name of parent entity | — |
Fagron NV
|
— |
| Name of ultimate parent of group | — |
Fagron NV
|
— |
| Statement of IFRS compliance [text block] | — |
De geconsolideerde jaarrekening van Fagron is opgesteld in overeenstemming met de Internationale Financiële Rapportering Standaarden (IFRS) zoals aanvaard door de Europese Unie (EU). De geconsolideerde jaarrekening is opgesteld op basis van de historische kostprijsgrondslag, met uitzondering van financiële afgeleide instrumenten en voorwaardelijke vergoedingsovereenkomsten welke tegen reële waarde worden opgenomen.
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
136,962
EUR
|
— |
113,938
EUR
|
| Current trade receivables |
81,963
EUR
|
— |
62,052
EUR
|
| Current trade payables |
114,276
EUR
|
— |
104,932
EUR
|
| Explanation of sources of estimation uncertainty with significant risk of causing material adjustment | — |
|
— |
| Disclosure of objectives, policies and processes for managing capital [text block] | — |
|
— |
| Dividends recognised as distributions to owners per share | — |
30.00
|
— |
| Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share | — |
35.00
|
— |